Search clinical trials for: Telithromycin (HMR3647)

Total 38 results

Sanofi

Terminated

Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections

Otitis Media

United States, France
Sanofi

Completed

Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis Media

Otitis Media

Japan
Sanofi

Completed

Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia

Pneumonia

Japan
Sanofi

Completed

Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections

Infections | Child

Japan
Sanofi

Terminated

TELI TON - Telithromycin in Tonsillitis

Tonsillitis | Pharyngitis

United States, Argentina, Chile, Costa Rica, Panama
Sanofi

Completed

Telithromycin in Respiratory Tract Infections

Respiratory Tract Infections
Sanofi

Completed

PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis

Chronic Bronchitis

France, Spain, Belgium, Hungary, United States, Turkey, Tunisia, Morocco
Sanofi

Terminated

Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days (COBRA II)

Pneumonia

United States
Melinta Therapeutics, Inc.

Completed

Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea

Uncomplicated Urogenital Gonorrhea

United States
Melinta Therapeutics, Inc.
Department of Health and Human Services

Completed

Pharmacokinetics and Safety of Solithromycin in Adolescents and Children

Bacterial Infection

United States, Bulgaria
Enanta Pharmaceuticals, Inc

Unknown

Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia

Community Acquired Pneumonia

United States
Melinta Therapeutics, Inc.

Completed

Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis

Nonalcoholic Steatohepatitis

United States
Sanofi

Completed

CHOOSE : Telithromycin, Acute Bacterial Sinusitis

Sinusitis
Sanofi

Completed

TELICAST : Telithromycin in Acute Exacerbations of Asthma

Asthma
Sanofi

Completed

Ketek in CAP / AECB in Ambulatory Adult Patients

Community Acquired Pneumonia (CAP) | Acute Exacerbation of Chronic Bronchitis (AECB)
Melinta Therapeutics, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea (SOLITAIRE-U)

Uncomplicated Urogenital Gonorrhea

United States, Australia
Sanofi

Completed

Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas

Pneumonia
Sanofi

Completed

Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD

Bronchitis, Chronic
Sanofi

Terminated

Telithromycin in Acute Exacerbation of Chronic Bronchitis

Bronchitis, Chronic

Turkey
CPL Associates
Sanofi

Terminated

Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis

Maxillary Sinusitis

United States
Sanofi

Terminated

TELI COM - Telithromycin in Children With Otitis Media

Otitis Media, Suppurative | Otitis Media, Purulent

United States, Canada, Chile, Argentina, Brazil, Czech Republic, Costa Rica, Panama, Colombia, Dominican Republic, Guatemala, Israel, Peru
Sanofi

Terminated

TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults

Tonsillitis | Pharyngitis

United States, Argentina, Chile, Costa Rica
CPL Associates
Sanofi

Withdrawn

Outpatient Registry Trial of Respiratory Tract Infections in Adults

Pneumonia, Bacterial | Bronchitis, Chronic

United States
Sanofi

Terminated

KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections (KEYS)

Respiratory Tract Infections | Pneumonia | Chronic Bronchitis

United States, Canada
National Institute of Allergy and Infectious Diseases...

Completed

Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin

Gonorrhoea

United States
Sanofi

Completed

AMS VS MOXI Ketek vs Avelox in AMS

Maxillary Sinusitis

United States
Dong-Min Kim

Completed

Controlled Trial: 5-day Course of Telithromycin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus

Scrub Typhus

Korea, Republic of
Melinta Therapeutics, Inc.
Department of Health and Human Services

Completed

Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents

Bacterial Infections

United States
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-ORAL)

Community-acquired Bacterial Pneumonia

Spain, United States, Hungary, Canada, Estonia, Russian Federation, Argentina, Bulgaria, Czech Republic, Dominican Republic, Ecuador, Germany, Latvia, Poland, Puerto Rico, Romania, South Africa
Imperial College London
Melinta Therapeutics, Inc.

Terminated

A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

United Kingdom
Bassett Healthcare
PriCara, Unit of Ortho-McNeil, Inc.

Completed

Comparative Effects of Azithromycin, Telithromycin and Levofloxacin on Drug Metabolizing Enzymes

Healthy
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination

Bacterial Infections | Healthy Volunteers

Australia
University of Illinois at Chicago
Sanofi

Terminated

Intrapulmonary Pharmacokinetics of Antibiotics

Healthy

United States
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-IV)

Community-acquired Bacterial Pneumonia

Spain, United States, Philippines, Taiwan, Canada, Germany, Poland, Russian Federation, Argentina, Bulgaria, South Africa, Slovenia, Serbia, Colombia, Hungary, Netherlands, Slovakia, Ukraine, Peru, Latvia, Guatemala, Romania, Chile, G... and more
Bayer
RTI Health Solutions

Completed

Risk of Acute Liver Injury in Users of Antimicrobials

Drug-Induced Liver Injury

United States
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Community-Acquired Bacterial Pneumonia

United States, Canada
Melinta Therapeutics, Inc.
Biomedical Advanced Research and Development Authority

Terminated

Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia

Community-acquired Bacterial Pneumonia

Spain, United States, Philippines, Hungary, United Kingdom, Bulgaria
The George Institute
National Health and Medical Research Council, Australia; Takeda; Conselho Nacional... and other collaborators

Completed

Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED) (ENCHANTED)

Ischemic Stroke | High Blood Pressure

Australia

Search clinical trials for: Telithromycin (HMR3647)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations